Insulet Corp (MEX:PODD)
MXN 4702.68 0 (0%) Market Cap: 372.46 Bil Enterprise Value: 382.28 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 87/100

Insulet Corp at Piper Sandler Healthcare Conference (Virtual) - Pre-Recorded Fireside Chat Transcript

Nov 23, 2020 / NTS GMT
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

All right. Hello, ladies and gentlemen. Thank you so much for joining us. This is Matt O'Brien, one of the medtech analysts here at Piper Sandler. I appreciate your time today and really appreciate the time from the Insulet management team. From the company is Shacey Petrovic, who is the President and CEO of the company; as well as Wayde McMillan, who is the Chief Financial Officer.

Thanks so much again for joining us.

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Great to be here.

Questions & Answers

Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

Excellent. So Shacey or Wayde, I guess to start with, I would love to hear about what you're seeing in terms of interest in diabetes technology as a result of COVID. Obviously, it's a terrible virus. But the thing that we've been hearing that's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot